Birdwatch Note
2023-03-13 19:34:47 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
BioNTech and Fosun Pharma partnered for BNT162b2 (or Comirnaty) to be distributed in China, not the United States or Europe according to legal documents. https://www.fiercepharma.com/manufacturing/biontech-fosun-pharma-eye-1b-doses-covid-19-vaccine-capacity-new-china-jv
Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1635352267061600275
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1635363798746820640
- noteId - 1635363798746820640
- participantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
- noteAuthorParticipantId -
- createdAtMillis - 1678736087869
- tweetId - 1635352267061600275
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- BioNTech and Fosun Pharma partnered for BNT162b2 (or Comirnaty) to be distributed in China, not the United States or Europe according to legal documents. https://www.fiercepharma.com/manufacturing/biontech-fosun-pharma-eye-1b-doses-covid-19-vaccine-capacity-new-china-jv
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-13 19:34:47 UTC (1678736087869) |
2023-03-14 18:38:28 UTC (1678819108346) |
CURRENTLY_RATED_HELPFUL | 2023-03-15 05:09:59 UTC (1678856999448) |
CURRENTLY_RATED_HELPFUL | 2023-03-14 18:38:28 UTC (1678819108346) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-03-14 17:09:09 -0500 | Rating Details | |
| 2023-03-14 13:06:53 -0500 | Rating Details | |
| 2023-03-14 12:33:28 -0500 | Rating Details | |
| 2023-03-14 12:25:43 -0500 | Rating Details | |
| 2023-03-14 11:34:40 -0500 | Rating Details | |
| 2023-03-14 10:42:04 -0500 | Rating Details | |
| 2023-03-14 04:35:02 -0500 | Rating Details | |
| 2023-03-14 03:08:41 -0500 | Rating Details | |
| 2023-03-14 00:19:37 -0500 | Rating Details | |
| 2023-03-13 22:14:30 -0500 | Rating Details | |
| 2023-03-13 21:55:48 -0500 | Rating Details | |
| 2023-03-13 17:20:14 -0500 | Rating Details | |
| 2023-03-13 16:07:05 -0500 | Rating Details | |
| 2023-03-13 15:02:38 -0500 | Rating Details | |
| 2023-03-13 14:38:47 -0500 | Rating Details | |
| 2023-03-15 16:44:18 -0500 | Rating Details | |
| 2023-03-15 09:04:18 -0500 | Rating Details | |
| 2023-03-13 17:20:14 -0500 | Rating Details | |
| 2023-03-13 14:38:47 -0500 | Rating Details | |
| 2023-03-14 12:25:43 -0500 | Rating Details | |
| 2023-03-14 13:06:53 -0500 | Rating Details | |
| 2023-03-14 11:34:40 -0500 | Rating Details | |
| 2023-03-14 10:42:04 -0500 | Rating Details | |
| 2023-03-14 00:19:37 -0500 | Rating Details | |
| 2023-03-13 15:02:38 -0500 | Rating Details | |
| 2023-03-14 17:09:09 -0500 | Rating Details | |
| 2023-03-13 22:14:30 -0500 | Rating Details | |
| 2023-03-14 12:33:28 -0500 | Rating Details | |
| 2023-03-13 16:07:05 -0500 | Rating Details | |
| 2023-03-15 09:04:18 -0500 | Rating Details | |
| 2023-03-14 04:35:02 -0500 | Rating Details | |
| 2023-03-14 03:08:41 -0500 | Rating Details | |
| 2023-03-13 21:55:48 -0500 | Rating Details | |
| 2023-03-15 16:44:18 -0500 | Rating Details |